On June 30, True Health Medical-B surged 165.45% in regular trading, trading at HK$342.0 per share, with turnover of HK$171 million. The stock made its trading debut on the Hong Kong Stock Exchange Main Board today, priced at HK$126.20 per share.

The company completed a global offering of approximately 3.56 million H shares, raising net proceeds of HK$384 million. The Hong Kong public offering was 1,790.4 times oversubscribed with a one-lot success rate of just 2.00%, reflecting extraordinary retail investor demand. In contrast, the international offering was 2.2 times subscribed with 107 placees. The final offer price of HK$126.20 was set below the indicative range midpoint of HK$127.40. During grey market trading prior to the official listing, the stock had already recorded gains exceeding 143%, signaling strong market expectations well above the IPO price.

True Health Medical is a China-based company engaged in the research, development, and commercialization of percutaneous puncture surgical and ablation surgical robots.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)